Cencora Non-Controlling Interest 2010-2025 | COR

Cencora non-controlling interest for the twelve months ending March 31, 2025 was $0.013B, a 85966.67% decline year-over-year.

  • Cencora annual non-controlling interest for 2024 was $0.01B, a 179.84% decline from 2023.
  • Cencora annual non-controlling interest for 2023 was $-0.013B, a 60.6% decline from 2022.
  • Cencora annual non-controlling interest for 2022 was $-0.032B, a 790.33% decline from 2021.

Cencora Non-Controlling Interest 2010-2025 | COR

  • Cencora annual non-controlling interest for 2024 was $0.01B, a 179.84% decline from 2023.
  • Cencora annual non-controlling interest for 2023 was $-0.013B, a 60.6% decline from 2022.
  • Cencora annual non-controlling interest for 2022 was $-0.032B, a 790.33% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$150.5B
CVS Health (CVS)$84.6B
Elevance Health (ELV)$66.5B
DiDi Global (DIDIY)$25.8B
Labcorp Holdings (LH)$22.5B
Natera (NTRA)$21.7B
BioMerieux (BMXMF)$17.2B
EUROFINS SCIENT (ERFSF)$15.5B
ICON (ICLR)$14.2B
CochLear (CHEOY)$13B
Medpace Holdings (MEDP)$12.9B
Solventum (SOLV)$12.7B
Viatris (VTRS)$12.5B
Caris Life Sciences,�Inc (CAI)$10.4B
Revvity (RVTY)$10.4B
Sonic Healthcare (SKHHY)$9.2B
Avantor (AVTR)$8.8B
Charles River Laboratories (CRL)$7.7B
HealthEquity (HQY)$7.6B
Bausch + Lomb (BLCO)$5B
Sotera Health (SHC)$4.5B
BrightSpring Health Services (BTSG)$4B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.5B
Concentras Parent (CON)$3B
Alignment Healthcare (ALHC)$2.9B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
Premier (PINC)$2B
Progyny (PGNY)$1.9B